Looks like IMMD is on the straight way to the 0.1+smth. range again. Products and IR need to gain more credibility. Has anyone seen an independent product review?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.